Rubius Therapeutics, Inc. Quarterly Other Liabilities, Noncurrent in USD from Q4 2018 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
Rubius Therapeutics, Inc. quarterly Other Liabilities, Noncurrent history and growth rate from Q4 2018 to Q4 2022.
  • Rubius Therapeutics, Inc. Other Liabilities, Noncurrent for the quarter ending December 31, 2022 was $0.000, a 100% decline year-over-year.
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $0 -$135K -100% Dec 31, 2022 10-K 2023-02-27
Q3 2022 $0 -$586K -100% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $67K -$553K -89.2% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $101K -$553K -84.6% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $135K -$553K -80.4% Dec 31, 2021 10-K 2023-02-27
Q3 2021 $586K -$298K -33.7% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $620K -$10K -1.59% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $654K +$283K +76.3% Mar 31, 2021 10-Q/A 2021-08-20
Q4 2020 $688K +$283K +69.9% Dec 31, 2020 10-K 2022-02-25
Q3 2020 $884K +$446K +102% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $630K +$26K +4.31% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $371K -$135K -26.7% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $405K +$96K +31.1% Dec 31, 2019 10-K 2021-02-23
Q3 2019 $438K Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $604K Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $506K Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $309K Dec 31, 2018 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.